A subset of lupus anti-DNA antibodies cross-reacts with the NR2 glutamate receptor in systemic lupus
Author: ["Lorraine A. DeGiorgio","Konstantin N. Konstantinov","Sunhee C. Lee","John A. Hardin","Bruce T. Volpe","Betty Diamond"]
Publication: Nature Medicine
CITE.CC academic search helps you expand the influence of your papers.
Abstract
In systemic lupus erythematosus, antibodies against double-stranded DNA are a major contributor to renal disease. We have previously demonstrated that the pentapeptide Asp/Glu-Trp-Asp/Glu-Tyr-Ser/Gly is a molecular mimic of double-stranded DNA. This sequence is also present in the extracellular domain of murine and human NMDA (N-methyl-d-aspartate) receptor subunits NR2a and NR2b. Here we show that the NR2 receptor is recognized by both murine and human anti-DNA antibodies. Moreover, anti-DNA antibodies with this cross-reactivity mediate apoptotic death of neurons in vivo and in vitro. Finally, we show that the cerebrospinal fluid of a patient with systemic lupus erythematosus contains these antibodies and also mediates neuronal death via an apoptotic pathway. These observations indicate that lupus antibodies cross-react with DNA and NMDA receptors, gain access to cerebrospinal fluid and may mediate non-thrombotic and non-vasculitic abnormalities of the central nervous system.
Cite this article
DeGiorgio, L., Konstantinov, K., Lee, S. et al. A subset of lupus anti-DNA antibodies cross-reacts with the NR2 glutamate receptor in systemic lupus erythematosus. Nat Med 7, 1189–1193 (2001). https://doi.org/10.1038/nm1101-1189